Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,711,298
-$40,960,877 QoQ
Shares Held
526,331
-69.5% QoQ
Ownership
0.718%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#32
of 210 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Venrock Adviser, LLC holds $3,294,790,938 across 31 Biotechnology names. ELVN ranks #20 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
8,493,321 | $1,127,318,496 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
4,148,428 | $394,805,892 | |
| 3 | ERAS |
Erasca, Inc.
|
17,891,812 | $327,777,995 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
2,985,448 | $265,048,073 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,180,000 | $115,026,400 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
|
10,346,926 | $101,606,813 | |
| 7 | DMRA |
Damora Therapeutics, Inc.
|
3,603,595 | $93,729,505 | |
| 8 | SVRA |
Savara Inc
|
14,745,943 | $90,835,008 |
All Filings in ELVN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,711,298 | 526,331 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $67,672,175 | 1,726,331 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $49,685,497 | 3,226,331 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $66,042,995 | 3,226,331 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $80,768,199 | 4,026,331 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $79,238,194 | 4,026,331 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $90,592,447 | 4,026,331 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $102,832,493 | 4,026,331 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $94,095,355 | 4,026,331 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $70,823,162 | 4,026,331 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $40,895,843 | 2,954,902 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $40,363,961 | 2,954,902 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $45,516,892 | 2,230,127 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $48,489,709 | 2,214,142 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||